Skip to main content
Clinical Trials/NCT04251442
NCT04251442
Withdrawn
Not Applicable

Randomized Controlled Trial of Patients Undergoing a Total Knee Arthroplasty With and Without the Use of Intraoperative Sensing Technology

Hospital for Special Surgery, New York1 site in 1 countryOctober 31, 2019
ConditionsOsteoarthritis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Hospital for Special Surgery, New York
Locations
1
Primary Endpoint
Knee Society Score
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to determine if there is a difference in clinical outcomes after total knee replacement (TKR) performed with traditional ligament balancing compared to use of intraoperative sensing technology (IOS) to balance ligaments. IOS is used to send real time information to a monitor within the operating room that assists your surgeon in making decisions about the balance of the ligaments in your knee and the proper insertion of implants. A total of 150 subjects will participate in this study at Hospital for Special Surgery.

The hypotheses are that the use of IOS technology will be associated with:

  1. Better soft tissue balance during TKR than by manual balancing alone.
  2. Higher patient reported clinical outcome measures (PROMs) following surgery.

Detailed Description

Participation in this study will involve a knee replacement performed with IOS. Patients will be randomized into one of two groups:The study group will have soft tissue balance performed with the use of IOS. Control group patients will have soft tissue balance performed manually, with final soft tissue balance values measured using IOS, while the surgeon will remain blinded to those values. Intra-operative compartment loads will be measured in 10, 45, and 90 degrees of flexion. Additionally, long leg limb alignment, passive range of motion, use of opioids, daily activity, and PROMS will be evaluated post-operatively to determine which group has better outcomes.

Registry
clinicaltrials.gov
Start Date
October 31, 2019
End Date
October 30, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital for Special Surgery, New York
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who meet the indications for use for primary TKR using IOS
  • Subject must be diagnosed with osteoarthritis
  • Subject is likely to be available for all study visits
  • Subject is able and willing to sign the informed consent and follow study procedures

Exclusion Criteria

  • Revision total knee arthroplasty
  • Patient is receiving treatment for any of the following conditions:
  • Avascular Necrosis
  • Inflammatory arthritis
  • Post-traumatic arthritis
  • Any knee surgery other than meniscectomy (can be arthroscopic or open)
  • Ligament insufficiencies, prior surgeries such as anterior cruciate ligament (ACL) or posterior cruciate ligament (PCL) reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures
  • Ipsilateral foot/ankle and hip arthritis
  • Range of motion less than 90°
  • Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e. severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease)

Outcomes

Primary Outcomes

Knee Society Score

Time Frame: 4 months

The primary outcome will be the difference in Knee Society Score (KSS) between baseline and 4 months post-operatively. The Knee Society Score is out of 100 points, with a higher score meaning a patient had a better outcome.

Secondary Outcomes

  • Intra-operative Compartment Loads(Intra-operative)
  • Long Leg Limb Alignment(6 weeks)
  • Passive Range of Motion(4 months)
  • Opioid Use(6 weeks)
  • Function and Activity(6 weeks)
  • Pain Level(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials